Abstract:Background Development of new drugs is a time-consuming and costly process, and the cost is still increasing in recent years. However, the number of drugs approved by FDA every year per dollar spent on development is declining. Drug repositioning, which aims to find new use of existing drugs, attracts attention of pharmaceutical researchers due to its high efficiency. A variety of computational methods for drug repositioning have been proposed based on machine learning approaches, network-based approaches, matrix decomposition approaches, etc. Results We propose a novel computational method for drug repositioning. We construct and decompose three-dimensional tensors, which consist of the associations among drugs, targets and diseases, to derive latent factors reflecting the functional patterns of the three kinds of entities. The proposed method outperforms several baseline methods in recovering missing associations. Most of the top predictions are validated by literature search and computational docking. Latent factors are used to cluster the drugs, targets and diseases into functional groups. Topological Data Analysis (TDA) is applied to investigate the properties of the clusters. We find that the latent factors are able to capture the functional patterns and underlying molecular mechanisms of drugs, targets and diseases. In addition, we focus on repurposing drugs for cancer and discover not only new therapeutic use but also adverse effects of the drugs. In the in-depth study of associations among the clusters of drugs, targets and cancer subtypes, we find there exist strong associations between particular clusters. Conclusions The proposed method is able to recover missing associations, discover new predictions and uncover functional clusters of drugs, targets and diseases. The clustering of drugs, targets and diseases, as well as the associations among the clusters, provides a new guiding framework for drug repositioning.

Deep learning of multimodal networks with topological regularization for drug repositioning

Deep learning of multimodal networks with topological regularization for drug repositioning

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Deep Multiple Instance Learning on Heterogeneous Graph for Drug-Disease Association Prediction.

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Heterogeneous multi-scale neighbor topologies enhanced drug-disease association prediction

Drug repositioning with adaptive graph convolutional networks

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

Drug Repositioning Method Based on Deep Neural Network

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Drug repositioning based on weighted local information augmented graph neural network

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Prediction of Drug-Disease Associations Based on Multi-Kernel Deep Learning Method in Heterogeneous Graph Embedding

Empowering Graph Neural Network-Based Computational Drug Repositioning with Large Language Model-Inferred Knowledge Representation

A weighted bilinear neural collaborative filtering approach for drug repositioning

Understanding Multivariate Drug-Target-DiseaseInterdependence Via Event-Graph.

deepDR: a network-based deep learning approach to in silico drug repositioning

Multi-Label Classification with Dual Tail-Node Augmentation for Drug Repositioning.